DC Field | Value | Language |
---|---|---|
dc.contributor.author | H J Lim | - |
dc.contributor.author | Hyun Sun Lee | - |
dc.contributor.author | J H Ryu | - |
dc.date.accessioned | 2017-04-19T09:10:16Z | - |
dc.date.available | 2017-04-19T09:10:16Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | 10.1007/s12272-001-1207-4 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/8431 | - |
dc.description.abstract | Activated microglia produce diverse neurotoxic factors such as nitric oxide (NO) and prostaglandin E2 (PGE2) that may cause neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. From the EtOAc soluble fraction of Farfarae flos (Tussilago farfara), we purified tussilagone as a bioactive compound by monitoring the inhibitory potential of NO production in activated microglia through the purification procedures. Tussilagone showed dose-dependent inhibition of NO and PGE 2 production in LPS-activated microglia with IC50 values of 8.67 μM and 14.1 μM, respectively. It suppressed the expression of protein and mRNA of inducible nitric oxide synthase and cyclooxygenase-2 through the inhibition of 1-κBα degradation and nuclear translocation of p65 subunit of NF-κB. Therefore tussilagone from Farfarae flos may have therapeutic potential in the treatment of neuro-inflammatory diseases through the inhibition of overproduction of NO and PGE2. | - |
dc.publisher | Pharmaceutical Soc Korea | - |
dc.title | Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression by tussilagone from farfarae flos in BV-2 microglial cells | - |
dc.title.alternative | Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression by tussilagone from farfarae flos in BV-2 microglial cells | - |
dc.type | Article | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.number | 5 | - |
dc.citation.endPage | 652 | - |
dc.citation.startPage | 645 | - |
dc.citation.volume | 31 | - |
dc.contributor.affiliatedAuthor | Hyun Sun Lee | - |
dc.contributor.alternativeName | 임효진 | - |
dc.contributor.alternativeName | 이현선 | - |
dc.contributor.alternativeName | 류재하 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, vol. 31, no. 5, pp. 645-652 | - |
dc.identifier.doi | 10.1007/s12272-001-1207-4 | - |
dc.subject.keyword | cyclooxygenase | - |
dc.subject.keyword | farfarae flos | - |
dc.subject.keyword | inhibitor kappaB-α | - |
dc.subject.keyword | nitric oxide | - |
dc.subject.keyword | nitric oxide synthase | - |
dc.subject.keyword | PGE 2 | - |
dc.subject.keyword | tussilagone | - |
dc.subject.local | Cyclooxygenase | - |
dc.subject.local | Cyclo-oxygenase | - |
dc.subject.local | Cyclooxygenases | - |
dc.subject.local | cyclooxygenase | - |
dc.subject.local | farfarae flos | - |
dc.subject.local | inhibitor kappaB-α | - |
dc.subject.local | NO | - |
dc.subject.local | nitric oxide | - |
dc.subject.local | nitric oxide (NO) | - |
dc.subject.local | Nitric oxide | - |
dc.subject.local | NO (Nitric oxide) | - |
dc.subject.local | nitric oxide. | - |
dc.subject.local | Nitric oxid | - |
dc.subject.local | Nitric oxide (NO) | - |
dc.subject.local | Nitric oxide synthase | - |
dc.subject.local | nitric oxide synthase | - |
dc.subject.local | PGE2 | - |
dc.subject.local | PGE 2 | - |
dc.subject.local | tussilagone | - |
dc.subject.local | Tussilagone | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.